Clinical Trial Update: Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating immunotherapy with or without SBRT in patients with stage IV non-small cell lung cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Metastatic Lung Cancer, Stage IV Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-06-13